| Literature DB >> 24394797 |
Sohinee Bhattacharya1, Marcus Beasley, Dong Pang, Gary J Macfarlane.
Abstract
OBJECTIVE: To investigate maternal and perinatal risk factors for childhood cancer. STUDYEntities:
Keywords: EPIDEMIOLOGY
Mesh:
Year: 2014 PMID: 24394797 PMCID: PMC3902197 DOI: 10.1136/bmjopen-2013-003656
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Comparison of maternal baseline characteristics between case children and control children
| Characteristics | Cases | Controls | p Value |
|---|---|---|---|
| Age at delivery (mean, SD) | 28.9 (5.6) | 30.2 (4.6) | 0.002 |
| Maternal social class | |||
| Manual | 26 (14.8%) | 79 (11.2%) | 0.187 |
| Non-manual | 62 (35.2%) | 295 (41.9%) | |
| Single/widowed | 87 (49.4%) | 325 (46.2%) | |
| Missing | 1 (0.6%) | 5 (0.7%) | |
| Paternal social class | |||
| Paternal manual | 71 (40.3%) | 329 (46.7%) | 0.193 |
| Paternal non-manual | 47 (26.7%) | 183 (26.0%) | |
| Maternal non-manual | 57 (32.4%) | 184 (26.1%) | |
| Missing | 1 (0.6%) | 8 (1.1%) | |
| Marital status | |||
| Single/widowed/divorced/separated | 62 (35.2%) | 222 (31.5%) | 0.324 |
| Married | 113 (64.2%) | 482 (68.4%) | |
| Missing | 1 (0.6%) | 0 (0%) | |
| BMI (mean, SD; missing cases=12, missing controls=39) | 25.2 (5.1) | 25.5 (5.1) | 0.407 |
| Smoking | |||
| Non-smoker | 107 (60.8%) | 477 (67.8%) | 0.034 |
| Smoker/ex-smoker | 68 (38.6%) | 209 (29.7%) | |
| Missing | 1 (0.6%) | 18 (2.6%) | |
BMI, body mass index.
Comparison of perinatal factors between cases and controls with statistically significant ORs shown in italics
| Perinatal factors | Cases N=176, % | Controls N=704, % | Unadjusted OR (95% CI) | Age and smoking adjusted OR (95% CI)—listwise deletion | Age and smoking adjusted OR (95% CI)—imputation of missing value |
|---|---|---|---|---|---|
| Pre-eclampsia | 11 (6.3) | 23 (3.3) | 1.98 (0.94 to 4.18) | 1.94 (0.88 to 4.28) | 1.92 (0.91 to 4.09) |
| Gestational hypertension | 19 (10.8) | 71 (10.1) | 1.09 (0.62 to 1.89) | 1.21 (0.67 to 2.17) | 1.13 (0.64 to 2.01) |
| Placenta praevia | 3 (1.7) | 4 (0.6) | 3.00 (0.67 to 13.40) | 3.46 (0.76 to 15.65) | 3.45 (0.76 to 15.62) |
| Abruption | 1 (0.6) | 4 (0.6) | 1.00 (0.11 to 8.95) | 1.31 (0.14 to 12.66) | 1.04 (0.12 to 9.41) |
| Other APH | 19 (10.8) | 77 (10.9) | 0.99 (0.58 to 1.68) | 0.98 (0.56 to 1.72) | 0.96 (0.56 to 1.65) |
| Previous miscarriage | 18 (10.2) | 103 (14.6) | 0.67 (0.39 to 1.13) | 0.83 (0.48 to 1.43) | 0.70 (0.41 to 1.19) |
| Preterm birth | 24 (13.6) | 47 (6.7) | |||
| Low birth weight | 17 (9.7) | 38 (5.4) | 1.81 (0.94 to 3.45) | 1.78 (0.97 to 3.28) | |
| Low Apgar at 1 min | 30 (17.1) | 107 (15.4) | 1.14 (0.73 to 1.78) | 1.14 (0.71 to 1.84) | 1.15 (0.73 to 1.81) |
| Low Apgar at 5 min | 8 (4.6) | 7 (1.0) | |||
| Delivery by caesarean | 55 (31.3) | 143 (20.4) | |||
| Instrumental delivery | 26 (14.8) | 144 (20.5) | 0.66 (0.41 to 1.04) | 0.68 (0.41 to 1.13) | 0.67 (0.42 to 1.08) |
| Intrauterine growth restriction | 23 (13.4) | 71 (10.3) | 1.41 (0.85 to 2.36) | 1.20 (0.68 to 2.12) | 1.35 (0.80 to 2.23) |
APH, antepartum haemorrhage.
ORs from multivariable model
| Perinatal factors | OR (95% CI) from multivariable model—listwise deletion* | OR (95% CI) from multivariable model—imputation of missing value* |
|---|---|---|
| Pre-eclampsia | 1.56 (0.68 to 3.59) | 1.55 (0.70 to 3.44) |
| Placenta praevia | 1.64 (0.32 to 8.34) | 1.65 (0.32 to 8.43) |
| Preterm birth | 1.60 (0.76 to 3.37) | 1.85 (0.92 to 3.72) |
| Low birth weight | 1.00 (0.44 to 2.28) | 0.90 (0.41 to 1.97) |
| Low Apgar at 5 min | ||
| Delivery by caesarean |
Statistically significant ORs are shown in italics.
*All variables adjusted for maternal age and smoking and for other variables in the model.
Distribution of sites of cancer
| Cancer site | Number | Per cent |
|---|---|---|
| C22—liver and intrahepatic bile ducts | 2 | 1.14 |
| C34—bronchus and lung | 2 | 1.14 |
| C41—bone and articular cartilage of other and unspecified sites | 10 | 5.68 |
| C49—other connective and soft tissue | 7 | 3.98 |
| C52—vagina | 5 | 2.84 |
| C56—ovary | 3 | 1.70 |
| C62—testis | 12 | 6.82 |
| C64—kidney except renal pelvis | 7 | 3.98 |
| C69—eye and adnexa | 6 | 3.41 |
| C71—brain | 27 | 15.34 |
| C72—spinal cord, cranial nerves, other CNS | 3 | 1.70 |
| C74—adrenal gland | 6 | 3.41 |
| C75—other endocrine glands and related structures | 4 | 2.27 |
| C76—other and ill-defined sites | 2 | 1.14 |
| C83—diffuse non-Hodgkin's lymphoma | 3 | 1.70 |
| C85—other and unspecified non-Hodgkin's | 2 | 1.14 |
| C91—lymphoid leukaemia | 37 | 21.02 |
| C92—myeloid leukaemia | 10 | 5.68 |
| C94—other leukaemias of specified cell type | 2 | 1.14 |
| D32—meninges | 3 | 1.70 |
| D40—Uncertain/unknown behaviour male genital | 2 | 1.14 |
| D43—uncertain/unknown behaviour brain and CNS | 2 | 1.14 |
| D44—uncertain/unknown behaviour Endocrine | 1 | 0.57 |
| D47—uncertain/unknown behaviour of lymphoid, haematopoietic and related tissue | 9 | 5.11 |
| D48—uncertain/unknown behaviour unknown sites | 9 | 5.11 |
CNS, central nervous system.